FAM
PRVB

Fred Alger Management’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Fred Alger Management’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,209
Closed -$388K – 514
2020
Q3 		$388K Sell
30,209
-14,791
-33% -$187K ﹤0.01% 391
2020
Q2 		$635K Buy
45,000
+38,000
+543% +$480K ﹤0.01% 382
2020
Q1 		$64K Buy
+7,000
New +$90.2K ﹤0.01% 411

Other funds holding PRVB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Fred Alger Management's PRVB Position: Q4 2020 in Review

Fred Alger Management sold out of Provention Bio, Inc. Common Stock (PRVB) in Q4 2020, closing a stake of 30,209 shares — an estimated $388K sold.

Fred Alger Management first reported a position in PRVB in Q1 2020 and held it in 3 quarters. The position peaked at $635K in Q2 2020. 106 funds tracked by Wall St. Rank hold PRVB as of Q4 2020.

  • Fred Alger Management reported no remaining Provention Bio, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Fred Alger Management sold 30,209 Provention Bio, Inc. Common Stock shares in Q4 2020, an estimated $388K.
  • Fred Alger Management first reported a position in Provention Bio, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Fred Alger Management's Provention Bio, Inc. Common Stock position peaked at $635K in Q2 2020.
  • 106 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q4 2020.

Based on Fred Alger Management's 13F filing for Q4 2020, filed 16 Feb 2021.